Literature DB >> 9538147

Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: distant metastasis and local recurrence.

K Isobe1, H Ito, N Shigematsu, T Kawada, S Yasuda, R Hara, N Machida, H Takano, Y Uchida, T Uno, H Kitahara, A Kubo.   

Abstract

One hundred and twenty-nine patients with NPC treated at the Department of Radiology, Chiba University Hospital and Keio University Hospital from 1980 through 1993 were selected for this study. Forty-four patients received cisplatin (CDDP)- or carboplatin-based chemotherapy, and 58 patients received adriamycin (ADM)- and/or 5-FU-based chemotherapy. The remaining 27 patients were treated with radiotherapy alone. The median radiation dose to the nasopharyngeal region was 64 Gy, and to the initially involved cervical node, 60 Gy. The 5 year survival rates for the CDDP, the ADM/5-FU and the radiation alone groups were 61%, 47% and 42%, respectively. The cumulative incidences of local control in the CDDP, the ADM/5-FU and the radiation alone groups were 77%, 49% and 53% respectively. The CDDP group achieved the significantly better local control (CDDP vs ADM: p=0.001). The overall incidence of distant metastases was 54% in the CDDP group. On the other hand, it was 24% in the ADM/5-FU group and 22% in the radiation alone group (CDDP vs ADM: p=0.048). While the locoregional control rate was significantly better in the CDDP given group, more distant metastases were seen in this group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538147     DOI: 10.3892/ijo.12.5.1183

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.

Authors:  Wen Liang Pan; Jack Ho Wong; Evandro Fei Fang; Yau Sang Chan; Tzi Bun Ng; Randy Chi Fai Cheung
Journal:  Biochem Pharmacol       Date:  2014-03-14       Impact factor: 5.858

2.  Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells.

Authors:  Hongbo Tang; Xinggu Luo; Juan Li; Yi Zhou; Yanmei Li; Lijuan Song; Xiaowen Zhang; Tao Chen
Journal:  Tumour Biol       Date:  2016-02-08

3.  Embelin prevents LMP1-induced TRAIL resistance via inhibition of XIAP in nasopharyngeal carcinoma cells.

Authors:  Shu Yang; Shi-Sheng Li; Xin-Ming Yang; Dan-Hui Yin; Lin Wang
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.